The patient’s condition worsens—he has developed a high fever, a cough, nausea and he is beginning to feel dizzy. He goes to the emergency room for tests, including blood and urine collection; during analysis, his condition continues to deteriorate.
true
Innovation at BD
Advancing the world of health™ for billions of people worldwide and addressing some of the greatest health challenges
Discover how our $1+ billion-dollars of innovation investment is empowering advances with...
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
- Overview
- Innovation and Engagement Center
- BD Idea Submission Process
Healthcare providers rely on us for comprehensive solutions across discovery, diagnostics and delivery of care at critical moments throughout their patients’ lives.
By leveraging our global network of cutting-edge science and technology, powerful partnerships and the brightest minds in med tech, we’re helping healthcare professionals and organizations achieve better outcomes and patient experiences, while optimizing care delivery.
As we continuously innovate our category-leading core platforms, we're also focused on three irreversible trends driving the future of healthcare.
Smart connected care
Artificial intelligence, informatics and robotics will transform healthcare processes, tools and treatments
Example areas:
- Smart medical devices
- Lab automation and informatics
- Connected medication management
New care settings
Shifts into new settings create major opportunities to improve patient outcomes and costs
Example areas:
- Point of care diagnostics
- Non-acute medication management
- Home urinary incontinence
Chronic disease outcomes
Medical technology will have a growing role in improving outcomes in chronic diseases
Example areas:
- Self-administered drug delivery
- Molecular diagnostics
- End-stage kidney disease
Explore
Explore
Explore
Exchange
Exchange
Experience
Experience
Engage
Engage
Educate
Educate
Excite
Excite
The patient visits his doctor to discuss his symptoms, particularly a lump he discovered a few days ago.
The specimens taken from the patient in the ER arrive at the sample reception area, where a range of chemistry and haematology tests are conducted.
The patient’s blood and urine specimens taken in the ER arrive at the microbiology laboratory for analysis to determine a diagnosis.
In the meantime, the patient is transferred to the intensive care unit as sepsis is suspected. He is under the care of the ICU to be closely monitored until his condition stabilises.
The patient returns to the hospital six months later with new complications; he is feeling very ill with severe abdominal pain. An examination and ultrasound confirm a mass consistent with lymphoma. The decision is taken to remove the tumour.
Seven days after surgery, the patient’s condition has improved and he is discharged. Following his recovery plan from surgery, he starts a new treatment for lymphoma on a pre-determined schedule.
Chemotherapy medications are prepared on-demand, specifically for each patient. The patient waits in the outpatient ward while the chemotherapy drugs are compounded in the aseptic pharmacy.
When the patient goes home, he has to manage multiple medications and their instructions, which can be complex. He knows he must be careful to take the right drugs, in the right quantity, at the right time.
Collaborate to innovate
Learn how BD is partnering with the healthcare community — researchers, clinicians, thought leaders and policymakers — to meet the needs of better patient care today and in the future.
WHAT'S NEW?
Find out more about BD events and the latest news.
Integrated systems panel session
Learn more about the role of integrated systems in medication error reduction, a BD-sponsored session at the International Forum on Quality and Safety in Healthcare
For over 25 years, the International Forum on Quality and Safety in Healthcare has brought together healthcare leaders, practitioners and patients annually from 80+ countries to share knowledge, ideas and expertise on patient safety. The forum addresses current and future healthcare challenges through collaboration, where attendees can exchange ideas, celebrate successes and help each other find solutions.
Patient Safety Day 2020
Hear from regional experts as they reflect on the changes and challenges in instilling a strong patient safety culture in the midst of a global pandemic in this BD Patient Safety Day webinar.
In honour of World Patient Safety Day 2020, the BD Patient Safety webinars aimed to increase awareness and engagement to support healthcare stakeholders in promoting safer care for all. This programme specifically emphasised the important link between patient safety and healthcare worker safety.
Improving safety by reducing risk
How can we best manage patient safety risks along the medication pathway? What role does technology play in error reduction? Learn about one successful approach to risk management and reduction of medication errors from a team of Spanish healthcare experts.
In honour of World Patient Safety Day 2020, the BD Patient Safety webinars aimed to increase awareness and engagement to support healthcare stakeholders in promoting safer care for all. This programme’s focus was safety in medication management.
BD Days Sepsis
The BD DAYS Sepsis agenda focused on sepsis challenges at the patient, institutional and health system levels and featured a broad spectrum of European leaders sharing their expertise across many disciplines.
The peer-based format provided insightful presentations, interactive panel discussions and inspirational case studies to accelerate the implementation of positive actions to better manage sepsis and help save lives.
The BD DAYS symposia series is designed to raise awareness and foster collaboration on key patient safety topics. Let us know if you’d like to be informed of future events.
Learn more
The Experience of Safety
This BD-sponsored paper by The Beryl Institute explores the significance of safety strategies in healthcare settings and how these practices influence both the patient and clinician experience. It reflects on the integrated nature of safety and service and how they interact to create the overall experience of patients, families and clinicians.
The paper acknowledges the success, failure and efficiency of all safety efforts are fundamental to the experience of patients and families. In addition, the safety systems in place in an organization directly shape and define the clinician’s experience.
Your idea may have the potential to impact the lives of millions of people. But a great idea is not enough.
To turn concept into reality, you need a relationship with an experienced medical technology innovator and manufacturer—one with the resources, expertise, and integrity to make it happen.
At BD, our success stems from partnering with inspired individuals and organizations on a global basis to bring innovative, new products that help manage or reduce costs, improve the patient experience and achieve better outcomes. Read more in the BD Idea Submission program brochure.
To learn more about the BD Idea Submission program, view the Idea Submission Brochure
As a global leader in healthcare, BD has the network and capabilities to bring your idea into mainstream use. We offer:
- More than 100 years of experience in medical technology and life sciences innovation, development, manufacturing, and commercialization
- Hundreds of products and solutions that are changing the landscape of health care
- Multiple new products and line extensions introduced annually
- A tradition of product and process innovation
- Early stage review of your idea by top-level R&D leaders in the company
- Research and development resources to enhance your product’s potential
- Hundreds of millions of dollars invested annually in the creation and acquisition of new technologies
- Needed infrastructure for global product manufacturing and distribution
×
![partner-idea-commercialization.png]()
To ensure prompt consideration and proper protection of your idea, please follow the steps below to submit your idea to BD:
- Complete the BD Idea Submission Form, paying special attention to the general description of your product. This is the baseline information that BD will need to determine whether your submission can be considered for further investigation.
- If more than one person has contributed to the concept, list all such persons on the BD Idea Submission Form.
- Following preliminary review, if BD is interested in moving forward, BD may request that both parties enter into a Confidentiality Agreement. This agreement allows for the exchange of more detailed information and helps protect both you and BD.
- BD will examine your idea thoroughly and contact you regarding next steps.
In your initial submission, please do not provide confidential information.
BD assumes no obligation to protect, retain, or hold confidential any information disclosed in any submission or in conversations prior to a formal written agreement between you and BD. BD may be aware of other products or concepts that could impact our decision to adopt your product idea.
To protect your product idea, we recommend applying for patent protection prior to submitting your proposal.
BD strives to generate the greatest social and commercial benefit from outside ideas. Should we move forward, BD will work with you to develop a mutually beneficial arrangement that may include license agreements for the development and commercialization of your product.
Send us an idea now through the online Idea Submission Form.
Not all products, services, claims or features of products may be available or valid in your local area. Please check with your local BD Representative.
true
